AP3S1 and pancreatic adenocarcinoma: Kaplan-Meier OS analysis demonstrated that elevated AP3S1 expression predicts BRCA, GBM, HNSC, KIRP, LIHC, LUAD, MESO, PAAD and UVM patients with poor overall survival (OS) (Figures 4B–J).